MDxHealth
MDXH
5 hedge funds and large institutions have $24.5M invested in MDxHealth in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.41% less ownership
Funds ownership: 19.66% → 19.25% (-0.41%)
16% less capital invested
Capital invested by funds: $29.1M → $24.5M (-$4.53M)
29% less funds holding
Funds holding: 7 → 5 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.64K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$344K |
| 2 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$190K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$63.5K |
| 4 |
Morgan Stanley
New York
|
-$15K |
MDXH Hedge Fund Activity: Q1 2022 in Review
5 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in MDxHealth (MDXH) for Q1 2022, worth a combined $24.5M — down 16% from $29.1M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of MDXH and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $2.64K. The largest seller was Altium Capital Management, exiting entirely with an estimated $344K sold.
- 5 institutional investors held MDxHealth (MDXH) as of Q1 2022, down from 7 in Q4 2021.
- Funds reported $24.5M of MDxHealth stock for Q1 2022, down 16% quarter-over-quarter.
- 1 fund opened new MDxHealth positions in Q1 2022 and 3 closed out, a net change of -2 holders.
- The largest MDxHealth buyer in Q1 2022 was UBS Group, an estimated $2.64K added.
- The largest MDxHealth seller in Q1 2022 was Altium Capital Management, an estimated $344K sold.
Based on aggregated 13F filings for Q1 2022.